| Code |
Title |
|
–
|
Top Categories
|
|
3 |
Administration
|
|
3E |
Physiological Systems and Anatomical Regions
|
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
|
3E08 |
Heart
|
|
3E080 |
Open
|
|
3E0801 |
Thrombolytic
|
|
3E08016
|
Recombinant Human-activated Protein C
Introduction of Recombinant Human-activated Protein C into Heart, Open
|
|
3E08017
|
Other Thrombolytic
Introduction of Other Thrombolytic into Heart, Open Approach
|
|
3E080G |
Other Therapeutic Substance
|
|
3E080GC
|
Other Substance
Introduction of Other Therapeutic Substance into Heart, Open Approach
|
|
3E080K |
Other Diagnostic Substance
|
|
3E080KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Heart, Open Approach
|
|
3E080P |
Platelet Inhibitor
|
|
3E080PZ
|
No Qualifier
Introduction of Platelet Inhibitor into Heart, Open Approach
|
|
3E083 |
Percutaneous
|
|
3E0831 |
Thrombolytic
|
|
3E08316
|
Recombinant Human-activated Protein C
Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous
|
|
3E08317
|
Other Thrombolytic
Introduction of Other Thrombolytic into Heart, Percutaneous Approach
|
|
3E083G |
Other Therapeutic Substance
|
|
3E083GC
|
Other Substance
Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach
|
|
3E083K |
Other Diagnostic Substance
|
|
3E083KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Heart, Percutaneous Approach
|
|
3E083P |
Platelet Inhibitor
|
|
3E083PZ
|
No Qualifier
Introduction of Platelet Inhibitor into Heart, Percutaneous Approach
|
|
3E084 |
Percutaneous Endoscopic
|
|
3E084G |
Other Therapeutic Substance
|
|
3E084GC
|
Other Substance
Introduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach
|